BioSpace News Archive

Genetown

Kernal Biologics Enters Development Phase Reaching Critical Milestones for its First mRNA-Based Cancer-Therapeutic Product

Kernal Biologics, Inc. is on a fast track to transition out of proof-of-concept phase to product development.

July 22, 2021
·
5 min read
Lone Star Bio

Volition’s Nu.Q® NETs Assay Demonstrates Promising Results in COVID-19 Risk Stratification and Disease Monitoring

VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”), has been working with researchers at two leading NHS Foundation Trusts on two studies in COVID-19 for which abstracts were released this week at the International Society on Thrombosis and Haemostasis (ISTH) Congress 2021.

July 22, 2021
·
6 min read
Genetown

Blueprint Medicines to Report Second Quarter 2021 Financial Results on Thursday, July 29, 2021

Blueprint Medicines Corporation (NASDAQ: BPMC), today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Thursday , July 29, 2021 to report its second quarter 2021 financial results and provide a corporate update.

July 22, 2021
·
1 min read
Pharm Country

Halberd Corp. Advances the Elimination of Antigens Present in Alzheimer’s Disease & PTSD/Chronic Traumatic Encephalopathy

Halberd Corporation confirms the shipment of samples of metallic nanoparticles conjugated to Alzheimer’s Disease antibodies, Tau and Phosphorylated Tau.

July 22, 2021
·
3 min read
ImmunoPrecise’s PolyTope™ TATX-03 Antibody Cocktail Potently Neutralizes SARS-CoV-2 Delta Variant in in vitro Pseudovirus Assays

ImmunoPrecise’s PolyTope™ TATX-03 Antibody Cocktail Potently Neutralizes SARS-CoV-2 Delta Variant in in vitro Pseudovirus Assays

July 22, 2021
·
6 min read
Pharm Country

Antares Pharma Announces FDA Acceptance of IND Application for ATRS-1902 for Adrenal Crisis Rescue

Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug Application (IND) for ATRS-1902 for adrenal crisis rescue

July 22, 2021
·
7 min read
Business

EOM Pharmaceuticals Appoints Drug Development Veteran Frank L. Douglas, Ph.D., M.D., Scientific Advisor

EOM Pharmaceuticals, Inc., a privately held, clinical-stage company, today announced the appointment of Frank L. Douglas , Ph.D., M.D., to Scientific Advisor.

July 22, 2021
·
5 min read
Business

Athenex to Provide Corporate and Financial Update for the Second Quarter 2021 on August 5, 2021

Athenex, Inc. today announced that the Company will provide a corporate and financial update for the second quarter 2021, on Thursday, August 5, 2021, before the market opens.

July 22, 2021
·
1 min read
Pharm Country

Todos Medical Receives New FDA Certificate of Free Sale for Tollovid Daily™ Including 3CL Protease Inhibitor Claim

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that the US Food & Drug Administration (FDA) has granted a new Certificate of Free Sale for Tollovid Daily™, the newest member of the Company’s Tollovid™ dietary supplement product line.

July 22, 2021
·
6 min read
Pharm Country

IHS Announces CE Mark Certification for Proprietary Syringe Infusion System

Innovative Health Sciences, LLC (“IHS” or the “Company”) announced today that they have received ISO 13485 quality management system and CE mark certification for the Insignis™ Syringe Infusion System.

July 22, 2021
·
2 min read